Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Arbutus Biopharma Corporation (ABUS) and Endologix Inc (ELGX)


Analysts have been eager to weigh in on the Healthcare sector with new ratings on RegenXBio (NASDAQ:RGNX), Arbutus Biopharma Corporation (NASDAQ:ABUS) and Endologix Inc (NASDAQ:ELGX).

RegenXBio (RGNX)

Barclays analyst Gena Wang maintained a Buy rating on RegenXBio today and set a price target of $83. The company’s shares closed on Friday at $67.40.

According to TipRanks.com, Wang is a 5-star analyst with an average return of 24.3% and a 54.1% success rate. Wang covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals Inc, Sarepta Therapeutics, and Mirati Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for RegenXBio with a $91.63 average price target, a 35.9% upside from current levels. In a report issued on August 8, Chardan Capital also reiterated a Buy rating on the stock with a $127.50 price target.

.

See today’s analyst top recommended stocks >>

Arbutus Biopharma Corporation (ABUS)

In a report released today, Robert Driscoll from Wedbush maintained a Hold rating on Arbutus Biopharma Corporation, with a price target of $7. The company’s shares closed on Friday at $9.45.

According to TipRanks.com, Driscoll has currently no stars on a ranking scale of 0-5 stars, with an average return of -14.4% and a 33.3% success rate. Driscoll covers the Healthcare sector, focusing on stocks such as Alpine Immune Sciences Inc, Five Prime Therapeutics, and Paratek Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Arbutus Biopharma Corporation with a $9.33 average price target, representing a -1.3% downside. In a report issued on August 6, B.Riley FBR also reiterated a Hold rating on the stock with a $9 price target.

.

Endologix Inc (ELGX)

BMO Capital analyst Joanne Wuensch maintained a Hold rating on Endologix Inc today and set a price target of $4. The company’s shares closed on Friday at $2.99, close to its 52-week low of $2.66.

According to TipRanks.com, Wuensch is a 5-star analyst with an average return of 12.3% and a 72.2% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Baxter International, and Edwards Lifesciences.

Endologix Inc has an analyst consensus of Hold, with a price target consensus of $4.55, representing a 52.2% upside. In a report issued on August 10, Piper Jaffray also downgraded the stock to Hold with a $4.75 price target.

.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts